日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: Yagolovich et al. DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma. Int. J. Mol. Sci. 2022, 23, 12687

更正：Yagolovich 等人，《DR5 选择性 TRAIL 变体 DR5-B 经肿瘤穿透性 iRGD 肽功能化增强抗胶质母细胞瘤活性》，《国际分子科学杂志》，2022 年，23 卷，12687 页。

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms25105334
Yagolovich, Anne V; Isakova, Alina A; Artykov, Artem A; Vorontsova, Yekaterina V; Mazur, Diana V; Antipova, Nadezhda V; Pavlyukov, Marat S; Shakhparonov, Mikhail I; Gileva, Anastasia M; Markvicheva, Elena A; Plotnikova, Ekaterina A; Pankratov, Andrey A; Kirpichnikov, Mikhail P; Gasparian, Marine E; Dolgikh, Dmitry A
TRAIL
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Impact of Variant Histology on Clinical and Pathological Outcomes in Patients with the Upper Urinary Tract Urothelial Carcinoma

变异组织学对上尿路尿路上皮癌患者临床和病理结果的影响

期刊:Medical Bulletin of Sisli Etfal Hospital
影响因子:0.9
doi:10.14744/SEMB.2021.23427
Artykov, Meylis; Haberal, Hakan Bahadır; Altan, Mesut; Kosemehmetoglu, Kemal; Yazici, Sertac; Ozen, Haluk; Akdogan, Bulent
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

ONC201-Induced Mitochondrial Dysfunction, Senescence-like Phenotype, and Sensitization of Cultured BT474 Human Breast Cancer Cells to TRAIL

ONC201 诱导的线粒体功能障碍、衰老样表型以及培养的 BT474 人乳腺癌细胞对 TRAIL 的敏感性

期刊:International Journal of Molecular Sciences
影响因子:0.7
doi:10.3390/ijms232415551
Artem Mishukov, Irina Odinokova, Ekaterina Mndlyan, Margarita Kobyakova, Serazhutdin Abdullaev, Vitaly Zhalimov, Xenia Glukhova, Vasiliy Galat, Yekaterina Galat, Anatoly Senotov, Roman Fadeev, Artem Artykov, Marine E Gasparian, Marina Solovieva, Igor Beletsky, Ekhson Holmuhamedov
免疫
细胞生物学
乳腺癌
肿瘤细胞
Senescence
发表日期：2022
文献求助 收藏

Optimized Heterologous Expression and Efficient Purification of a New TRAIL-Based Antitumor Fusion Protein SRH-DR5-B with Dual VEGFR2 and DR5 Receptor Specificity

具有 VEGFR2 和 DR5 受体双重特异性的新型 TRAIL 抗肿瘤融合蛋白 SRH-DR5-B 的优化异源表达和高效纯化

期刊:International Journal of Molecular Sciences
影响因子:0.7
doi:10.3390/ijms23115860
Anne V Yagolovich, Artem A Artykov, Alina A Isakova, Yekaterina V Vorontsova, Dmitry A Dolgikh, Mikhail P Kirpichnikov, Marine E Gasparian
肿瘤
发表日期：2022
文献求助 收藏

DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma

DR5 选择性 TRAIL 变体 DR5-B 与肿瘤穿透性 iRGD 肽功能化，可增强对胶质母细胞瘤的抗肿瘤活性

期刊:International Journal of Molecular Sciences
影响因子:0.7
doi:10.3390/ijms232012687
Anne V Yagolovich, Alina A Isakova, Artem A Artykov, Yekaterina V Vorontsova, Diana V Mazur, Nadezhda V Antipova, Marat S Pavlyukov, Mikhail I Shakhparonov, Anastasia M Gileva, Elena A Markvicheva, Ekaterina A Plotnikova, Andrey A Pankratov, Mikhail P Kirpichnikov, Marine E Gasparian, Dmitry A Dolgi
肿瘤
胶质瘤
其它细胞
发表日期：2022
文献求助 收藏

Amphiphilic Poly(N-vinylpyrrolidone) Nanoparticles Conjugated with DR5-Specific Antitumor Cytokine DR5-B for Targeted Delivery to Cancer Cells

两亲性聚（N-乙烯基吡咯烷酮）纳米颗粒与DR5特异性抗肿瘤细胞因子DR5-B偶联，用于靶向递送至癌细胞

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics13091413
Yagolovich, Anne; Kuskov, Andrey; Kulikov, Pavel; Kurbanova, Leily; Bagrov, Dmitry; Artykov, Artem; Gasparian, Marine; Sizova, Svetlana; Oleinikov, Vladimir; Gileva, Anastasia; Kirpichnikov, Mikhail; Dolgikh, Dmitry; Markvicheva, Elena
肿瘤
肿瘤免疫
细胞生物学
肿瘤细胞
免疫/内分泌
发表日期：2021
文献求助 收藏

Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL

无论癌细胞对TRAIL的敏感性如何，死亡受体DR4和DR5都会发生自发性和配体介导的内吞作用和再循环。

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2021.733688
Artykov, Artem A; Yagolovich, Anne V; Dolgikh, Dmitry A; Kirpichnikov, Mikhail P; Trushina, Daria B; Gasparian, Marine E
肿瘤
肿瘤免疫
信号转导
TRAIL
细胞生物学
发表日期：2021
文献求助 收藏

Corrigendum: Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL

更正：死亡受体DR4和DR5无论癌细胞对TRAIL的敏感性如何，都会发生自发性和配体介导的内吞作用和再循环。

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2021.820069
Artykov, Artem A; Yagolovich, Anne V; Dolgikh, Dmitry A; Kirpichnikov, Mikhail P; Trushina, Daria B; Gasparian, Marine E
肿瘤
肿瘤免疫
信号转导
TRAIL
细胞生物学
发表日期：2021
文献求助 收藏

Minimally Invasive Partial Nephrectomy in the Era of Robotic Surgery

机器人手术时代的微创部分肾切除术

期刊:Medical Bulletin of Sisli Etfal Hospital
影响因子:0.9
doi:10.14744/SEMB.2020.33230
Haberal, Hakan Bahadir; Artykov, Meylis; Gudeloglu, Ahmet; Yazici, Sertac; Bilen, Cenk Yucel
发表日期：2021
文献求助 收藏

Genetically Modified DR5-Specific TRAIL Variant DR5-B Revealed Dual Antitumor and Protumoral Effect in Colon Cancer Xenografts and an Improved Pharmacokinetic Profile

转基因 DR5 特异性 TRAIL 变体 DR5-B 在结肠癌异种移植中表现出双重抗肿瘤和促肿瘤作用，且药代动力学特征得到改善

期刊:Translational Oncology
影响因子:4.5
doi:10.1016/j.tranon.2020.100762
Anne V Yagolovich, Artem A Artykov, Tatiana A Karmakova, Maria S Vorontsova, Andrey A Pankratov, Alexander A Andreev-Andrievsky, Dmitry A Dolgikh, Mikhail P Kirpichnikov, Marine E Gasparian
肿瘤
肠癌
发表日期：2020
文献求助 收藏